Name: Global Bio Similars/Subsequent Entry Biologic Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.9 (176 reviews)

Global Bio Similars/Subsequent Entry Biologic Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The study also focuses primarily on the revenue and forecast based on a variety of segmentation along with a global segmentation. The study also pinpoints vital and detailed statistics about the current market scenarios along with a variety of aspects, leading key players along with key strategies that are employed in the decision making. The latest Bio Similars/Subsequent Entry Biologic Market study that is published offers the latest complementary analysis and a global market estimate that are developed using an in-house analytical method which is developed on years of analytical experience. The analysis provides a clear path for the international market for the Bio Similars/Subsequent Entry Biologic scenario with respect to global scale as well as major markets that are encapsulated within the study.

Data provided by Extent Research. Source: https://www.extentresearch.com/bio-similars-subsequent-entry-biologic-market

The study also sheds light on the current economic sanctions that the market has witnessed along with a detailed sanction that the market can bear in the forecast. The Bio Similars/Subsequent Entry Biologic market study is divided into various segments that segregates the market into sections which further make the study more readable and easier to grasp for the readers. The competitive landscape of the market study includes a wider analysis on the regions including by Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa, which are expected to capture the essence of the market in its widest category. Some of the key players operating in the global Bio Similars/Subsequent Entry Biologic market includes Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy’s Laboratories, Stada Arzneimittel AG, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, .

Segmentation of the Global Bio Similars/Subsequent Entry Biologic Market:

Product type

Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other,

by Application

Tumor, Diabetes, Cardiovascular, Hemophilia, Other,

The main analytical advantages of acquiring this market study are as follows:

Offers better insights on the Bio Similars/Subsequent Entry Biologic market by pointing out the sub-segments of the market
Analyzes profiles of the key players and their growth patterns
Analyzes prospects, market drivers, and restraints of the Bio Similars/Subsequent Entry Biologic market on the basis of types and applications of the market
Global segmentation of the Bio Similars/Subsequent Entry Biologic market in terms of local and national growth
Examines and analyzes various external factors that govern the Bio Similars/Subsequent Entry Biologic markets such as expansions, latest product launches, and acquisitions

Report Scope and Market Segmentation

ATTRIBUTES	Global Bio Similars/Subsequent Entry Biologic Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Bio Similars/Subsequent Entry Biologic Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Monoclonal Antibodies
        1.2.3 Interferon
        1.2.4 Erythropoietin
        1.2.5 Insulin
        1.2.6 Vaccines
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Bio Similars/Subsequent Entry Biologic Market Perspective (2017-2035)
    2.2 Bio Similars/Subsequent Entry Biologic Growth Trends by Region
        2.2.1 Bio Similars/Subsequent Entry Biologic Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Bio Similars/Subsequent Entry Biologic Historic Market Size by Region (2017-2022)
        2.2.3 Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Region (2023-2035)
    2.3 Bio Similars/Subsequent Entry Biologic Market Dynamics
        2.3.1 Bio Similars/Subsequent Entry Biologic Industry Trends
        2.3.2 Bio Similars/Subsequent Entry Biologic Market Drivers
        2.3.3 Bio Similars/Subsequent Entry Biologic Market Challenges
        2.3.4 Bio Similars/Subsequent Entry Biologic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue
        3.1.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue (2017-2022)
        3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2017-2022)
    3.2 Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Bio Similars/Subsequent Entry Biologic Revenue
    3.4 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio
        3.4.1 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Bio Similars/Subsequent Entry Biologic Revenue in 2021
    3.5 Bio Similars/Subsequent Entry Biologic Key Players Head office and Area Served
    3.6 Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
    3.7 Date of Enter into Bio Similars/Subsequent Entry Biologic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Similars/Subsequent Entry Biologic Breakdown Data by Type
    4.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Type (2017-2022)
    4.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2023-2035)
5 Bio Similars/Subsequent Entry Biologic Breakdown Data by Application
    5.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Application (2017-2022)
    5.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Bio Similars/Subsequent Entry Biologic Market Size (2017-2035)
    6.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type
        6.2.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        6.2.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2035)
        6.2.3 North America Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2035)
    6.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Application
        6.3.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        6.3.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2035)
        6.3.3 North America Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2035)
    6.4 North America Bio Similars/Subsequent Entry Biologic Market Size by Country
        6.4.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        6.4.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Bio Similars/Subsequent Entry Biologic Market Size (2017-2035)
    7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type
        7.2.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        7.2.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2035)
        7.2.3 Europe Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2035)
    7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application
        7.3.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        7.3.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2035)
        7.3.3 Europe Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2035)
    7.4 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country
        7.4.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        7.4.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size (2017-2035)
    8.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type
        8.2.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2035)
    8.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application
        8.3.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2035)
    8.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region
        8.4.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size (2017-2035)
    9.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type
        9.2.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        9.2.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2035)
        9.2.3 Latin America Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2035)
    9.3 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application
        9.3.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        9.3.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2035)
        9.3.3 Latin America Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2035)
    9.4 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country
        9.4.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        9.4.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size (2017-2035)
    10.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type
        10.2.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2035)
    10.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application
        10.3.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2035)
    10.4 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country
        10.4.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Sun Pharma
        11.1.1 Sun Pharma Company Details
        11.1.2 Sun Pharma Business Overview
        11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Introduction
        11.1.4 Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.1.5 Sun Pharma Recent Developments
    11.2 Synthon Pharmaceuticals
        11.2.1 Synthon Pharmaceuticals Company Details
        11.2.2 Synthon Pharmaceuticals Business Overview
        11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Introduction
        11.2.4 Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.2.5 Synthon Pharmaceuticals Recent Developments
    11.3 Teva Pharmaceutical Industries
        11.3.1 Teva Pharmaceutical Industries Company Details
        11.3.2 Teva Pharmaceutical Industries Business Overview
        11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Introduction
        11.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.3.5 Teva Pharmaceutical Industries Recent Developments
    11.4 LG Life Sciences
        11.4.1 LG Life Sciences Company Details
        11.4.2 LG Life Sciences Business Overview
        11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Introduction
        11.4.4 LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.4.5 LG Life Sciences Recent Developments
    11.5 Celltrion Biocon
        11.5.1 Celltrion Biocon Company Details
        11.5.2 Celltrion Biocon Business Overview
        11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Introduction
        11.5.4 Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.5.5 Celltrion Biocon Recent Developments
    11.6 Hospira
        11.6.1 Hospira Company Details
        11.6.2 Hospira Business Overview
        11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Introduction
        11.6.4 Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.6.5 Hospira Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Bio Similars/Subsequent Entry Biologic Introduction
        11.7.4 Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Biogen idec
        11.8.1 Biogen idec Company Details
        11.8.2 Biogen idec Business Overview
        11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Introduction
        11.8.4 Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.8.5 Biogen idec Recent Developments
    11.9 Genentech (Roche)
        11.9.1 Genentech (Roche) Company Details
        11.9.2 Genentech (Roche) Business Overview
        11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Introduction
        11.9.4 Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.9.5 Genentech (Roche) Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Introduction
        11.10.4 Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.10.5 Pfizer Recent Developments
    11.11 Celltrion
        11.11.1 Celltrion Company Details
        11.11.2 Celltrion Business Overview
        11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Introduction
        11.11.4 Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.11.5 Celltrion Recent Developments
    11.12 Biocon
        11.12.1 Biocon Company Details
        11.12.2 Biocon Business Overview
        11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Introduction
        11.12.4 Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.12.5 Biocon Recent Developments
    11.13 Amgen
        11.13.1 Amgen Company Details
        11.13.2 Amgen Business Overview
        11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Introduction
        11.13.4 Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.13.5 Amgen Recent Developments
    11.14 Samsung Biologics
        11.14.1 Samsung Biologics Company Details
        11.14.2 Samsung Biologics Business Overview
        11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Introduction
        11.14.4 Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.14.5 Samsung Biologics Recent Developments
    11.15 Mylan
        11.15.1 Mylan Company Details
        11.15.2 Mylan Business Overview
        11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Introduction
        11.15.4 Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.15.5 Mylan Recent Developments
    11.16 Dr. Reddy's Laboratories
        11.16.1 Dr. Reddy's Laboratories Company Details
        11.16.2 Dr. Reddy's Laboratories Business Overview
        11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Introduction
        11.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.16.5 Dr. Reddy's Laboratories Recent Developments
    11.17 Stada Arzneimittel AG
        11.17.1 Stada Arzneimittel AG Company Details
        11.17.2 Stada Arzneimittel AG Business Overview
        11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Introduction
        11.17.4 Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.17.5 Stada Arzneimittel AG Recent Developments
    11.18 AbbVie
        11.18.1 AbbVie Company Details
        11.18.2 AbbVie Business Overview
        11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Introduction
        11.18.4 AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.18.5 AbbVie Recent Developments
    11.19 Sanofi-Aventis
        11.19.1 Sanofi-Aventis Company Details
        11.19.2 Sanofi-Aventis Business Overview
        11.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Introduction
        11.19.4 Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.19.5 Sanofi-Aventis Recent Developments
    11.20 Johnson & Johnson
        11.20.1 Johnson & Johnson Company Details
        11.20.2 Johnson & Johnson Business Overview
        11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Introduction
        11.20.4 Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.20.5 Johnson & Johnson Recent Developments
    11.21 Novo Nordisk
        11.21.1 Novo Nordisk Company Details
        11.21.2 Novo Nordisk Business Overview
        11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Introduction
        11.21.4 Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.21.5 Novo Nordisk Recent Developments
    11.22 Eli Lilly
        11.22.1 Eli Lilly Company Details
        11.22.2 Eli Lilly Business Overview
        11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Introduction
        11.22.4 Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.22.5 Eli Lilly Recent Developments
    11.23 Novartis
        11.23.1 Novartis Company Details
        11.23.2 Novartis Business Overview
        11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Introduction
        11.23.4 Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.23.5 Novartis Recent Developments
    11.24 3sbio
        11.24.1 3sbio Company Details
        11.24.2 3sbio Business Overview
        11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Introduction
        11.24.4 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.24.5 3sbio Recent Developments
    11.25 Biotech
        11.25.1 Biotech Company Details
        11.25.2 Biotech Business Overview
        11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Introduction
        11.25.4 Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.25.5 Biotech Recent Developments
    11.26 Gelgen
        11.26.1 Gelgen Company Details
        11.26.2 Gelgen Business Overview
        11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Introduction
        11.26.4 Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.26.5 Gelgen Recent Developments
    11.27 Innovent
        11.27.1 Innovent Company Details
        11.27.2 Innovent Business Overview
        11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Introduction
        11.27.4 Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.27.5 Innovent Recent Developments
    11.28 Dong Bao
        11.28.1 Dong Bao Company Details
        11.28.2 Dong Bao Business Overview
        11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Introduction
        11.28.4 Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.28.5 Dong Bao Recent Developments
    11.29 Ganlee
        11.29.1 Ganlee Company Details
        11.29.2 Ganlee Business Overview
        11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Introduction
        11.29.4 Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.29.5 Ganlee Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Bio Similars/Subsequent Entry Biologic Market